5/30
08:54 am
tnxp
Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting [Yahoo! Finance]
5/30
08:00 am
tnxp
Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting
Low
Report
Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting
5/29
08:00 am
tnxp
Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024
Low
Report
Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024
5/29
01:18 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/28
08:00 am
tnxp
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
Medium
Report
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
5/28
05:36 am
tnxp
Binge Eating Disorder Market to Accelerate Substantially During the Study Period (2020-2034) | DelveInsight [Yahoo! Finance]
Medium
Report
Binge Eating Disorder Market to Accelerate Substantially During the Study Period (2020-2034) | DelveInsight [Yahoo! Finance]
5/22
08:00 am
tnxp
Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Low
Report
Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
5/21
08:11 am
tnxp
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia [Yahoo! Finance]
5/21
08:00 am
tnxp
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia
Medium
Report
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia
5/21
03:06 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/15
08:00 am
tnxp
Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Low
Report
Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
5/13
04:34 pm
tnxp
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
5/13
04:30 pm
tnxp
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
Low
Report
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
5/13
03:02 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
5/5
02:34 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/27
02:05 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/24
08:00 am
tnxp
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
Medium
Report
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
4/19
02:08 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/11
02:04 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/3
02:04 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/1
04:21 pm
tnxp
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights [Yahoo! Finance]
4/1
04:15 pm
tnxp
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Low
Report
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
3/28
09:35 am
tnxp
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering [Yahoo! Finance]
High
Report
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering [Yahoo! Finance]
3/28
09:32 am
tnxp
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
High
Report
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
3/26
02:32 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.